Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Tecfidera
Research
New insight into Tecfidera may lead to better MS therapies
Scientists from CUNY and the Icahn School of Medicine have identified a possible mechanism of action for Biogen's MS drug Tecfidera.
Angus Liu
Feb 28, 2019 12:14pm
Biogen’s MS drug could make cancer-killing viruses more potent
Jan 25, 2018 3:00pm
Biogen inks Alkermes deal to defend multiple sclerosis turf
Nov 27, 2017 9:20am